Regulation of expression of the human lymphocyte activation gene-3 (LAG-3) molecule, a ligand for MHC class II (original) (raw)
Abstract
The lymphocyte activation gene-3 (LAG-3), a major histocompatibility complex (MHC) class II ligand evolutionarily related to CD4, is expressed exclusively in activated T and NK lymphocytes and seems to play a role in regulating the evolving immune response. We first determined that surface LAG-3 expression on activated human T cells is upregulated by certain cytokines (IL-2, IL-7, IL-12) and not by others (IL-4, IL-6, IL-10, TNF-α, TNF-β, IFN-γ). Surface LAG-3 expression correlated with intracellular IFN-γ production in both CD4+ and CD8+ T-cell subsets. We then analyzed the 5’ transcription control sequences of LAG-3. A DNase I hypersensitive site induced in T cells following cellular activation was found in the region including the transcriptional start site, showing that DNA accessibility is a mechanism which restricts LAG-3 expression to activated T cells. Transcription is initiated at three sites. A GC box, 80 base pairs (bp) upstream of the major transcription start site, forms a minimal promoter which is regulated by two upstream regions containing positive and negative regulatory elements with multiple protein binding sites as shown by footprinting analysis. In particular, a GATA/c-Ets motive was identified in a short segment homologous to the mouse CD4 distal enhancer, suggesting that LAG-3, which is embedded in the CD4 locus, may be controlled by some CD4 regulatory elements. Finally, a 100 bp region downstream of the transcription start site was shown to be involved in the cell-specific control of LAG-3 expression. Understanding this highly regulated expression may help to determine the intriguing role of this activation-induced MHC class II ligand.
Access this article
Subscribe and save
- Get 10 units per month
- Download Article/Chapter or eBook
- 1 Unit = 1 Article or 1 Chapter
- Cancel anytime Subscribe now
Buy Now
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Instant access to the full article PDF.
Similar content being viewed by others
Author information
Authors and Affiliations
- Laboratoire d’Immunologie Cellulaire, Institut Gustave Roussy 39, rue Camille Desmoulins, F-94805 Villejuif Cedex, France, , , , , , FR
D. Bruniquel, N. Borie, S. Hannier & F. Triebel
Authors
- D. Bruniquel
You can also search for this author inPubMed Google Scholar - N. Borie
You can also search for this author inPubMed Google Scholar - S. Hannier
You can also search for this author inPubMed Google Scholar - F. Triebel
You can also search for this author inPubMed Google Scholar
Additional information
Received: 26 November 1997 / Revised: 23 December 1997
Rights and permissions
About this article
Cite this article
Bruniquel, D., Borie, N., Hannier, S. et al. Regulation of expression of the human lymphocyte activation gene-3 (LAG-3) molecule, a ligand for MHC class II.Immunogenetics 48, 116–124 (1998). https://doi.org/10.1007/s002510050411
- Issue Date: June 1998
- DOI: https://doi.org/10.1007/s002510050411